Logo-ipp

Original

1. Cost-effectiveness analysis of infliximab versus CinnoRA in the treatment of moderate to severe ulcerative colitis in Iranian patients
Meysam Olfatifar ORCID, Hamid Asadzadeh Aghdaei* ORCID, Ayda Hasanpour Dehkordi ORCID, Shabnam Shahrokh, Mohamad Amin Pourhoseingholi ORCID, Hedieh Balaii ORCID, Mohsen Rajabnia ORCID, Maria Ivanchuk ORCID, Pavlo Ivanchuk ORCID, Saeed Hashemi Nazari* ORCID, Siamak Sabour ORCID, Pejman Rohani ORCID, Gholamhossein Mehralian ORCID, Soheila Khodakarim ORCID, Behzad Hatami ORCID, Habib Malekpour, Ghazal Sherkat ORCID, Mohammad Reza Zali* ORCID, Sajjad Rahimi Pordanjani ORCID
Immunopathol Persa. 2023;9(2): 29293. doi: 10.34172/ipp.2022.29293
Scopus ID: 85164616699    
Article
PDF
XML
Cited By:
0
0